Shantanu Dhamija

Shan joined Molecular Devices in April 2021 as Vice President of Strategy and Innovation to lead strategic planning and inorganic growth initiatives. He comes from Leica Biosystems, a Danaher company, where he started in 2014 as Director of Strategy and Market Analytics and was responsible for Strategic Planning, Mergers and Acquisitions (M&A) market work, and Market Intelligence. In 2017, his responsibilities evolved from driving commercial strategy and commercial process improvement to leading a 35-person Customer Care and Inside Sales group. Leveraging the Danaher Business System, he drove double-digit reductions in customer service order rework and established Inside Sales as a $80M channel, while helping increase his team’s engagement by nearly 70 percent.

Prior to Danaher, Shan was a part of Deloitte Consulting's Healthcare and Life Sciences Strategy and M&A practice. He earned his MBA and graduate degrees in Electrical and Biomedical Engineering from the University of Michigan, Ann Arbor, and his bachelor’s degree in Electrical Engineering from the University of Delhi, India.